Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae

Diagnostic Microbiology and Infectious Disease

Volumn 77, Issue 3, 2013, Pages 179-194

  Lupo, Agnese ^a   Papp Wallace, Krisztina M ^b,c   Sendi, Parham ^a   Bonomo, Robert A ^b,c   Endimiani, Andrea ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Louis Stokes Cleveland Veterans Administration   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbapenemases; ESBL; MALDI TOF; Microarray; Multiplex; PCR; Real time

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN; CHLORAMPHENICOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; CONCENTRATION RESPONSE; COST BENEFIT ANALYSIS; DNA SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; ENTEROBACTERIACEAE; GENE TARGETING; GENETIC ANALYSIS; GENETIC TRAIT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY;

CARBAPENEMASES; ESBL; MALDI-TOF; MICROARRAY; MULTIPLEX; PCR; REAL-TIME;

ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 84885390721     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.06.001     Document Type: Review

References (206)

1. Akinci E., Vahaboglu H. Minor extended-spectrum β-lactamases. Expert Rev Anti Infect Ther 2010, 8:1251-1258.
2. Ambrozic Avgustin J., Keber R., Zerjavic K., Orazem T., Grabnar M. Emergence of the quinolone resistance-mediating gene aac(6')-Ib-cr in extended-spectrum-beta-lactamase-producing Klebsiella isolates collected in Slovenia between 2000 and 2005. Antimicrob Agents Chemother 2007, 51:4171-4173.
3. Arya M., Shergill I.S., Williamson M., Gommersall L., Arya N., Patel H.R. Basic principles of real-time quantitative PCR. Expert Rev Mol Diagn 2005, 5:209-219.
4. Avlami A., Bekris S., Ganteris G., Kraniotaki E., Malamou-Lada E., Orfanidou M., et al. Detection of metallo-β-lactamase genes in clinical specimens by a commercial multiplex PCR system. J Microbiol Methods 2010, 83:185-187.
5. Batchelor M., Hopkins K.L., Liebana E., Slickers P., Ehricht R., Mafura M., et al. Development of a miniaturised microarray-based assay for the rapid identification of antimicrobial resistance genes in Gram-negative bacteria. Int J Antimicrob Agents 2008, 31:440-451.
6. Bell J.M., Turnidge J.D., Andersson P. aac(6')-Ib-cr genotyping by simultaneous high-resolution melting analyses of an unlabeled probe and full-length amplicon. Antimicrob Agents Chemother 2010, 54:1378-1380.
7. Bercot B., Poirel L., Nordmann P. Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers. Diagn Microbiol Infect Dis 2011, 71:442-445.
8. Birkett C.I., Ludlam H.A., Woodford N., Brown D.F., Brown N.M., Roberts M.T., et al. Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum β-lactamases. J Med Microbiol 2007, 56:52-55.
9. IMP metallo-β-lactamase genes in a single real-time PCR. Clin Microbiol Infect 2007, 13:1201-1203.
10. Blaschke A.J., Heyrend C., Byington C.L., Fisher M.A., Barker E., Garrone N.F., et al. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 2012, 74:349-355.
11. Bogaerts P., Hujer A.M., Naas T., de Castro R.R., Endimiani A., Nordmann P., et al. Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from β-lactam-resistant gram-negative bacteria. Antimicrob Agents Chemother 2011, 55:4457-4460.
12. Boyd D.A., Tyler S., Christianson S., McGeer A., Muller M.P., Willey B.M., et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004, 48:3758-3764.
13. Bradford P.A., Bratu S., Urban C., Visalli M., Mariano N., Landman D., et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin Infect Dis 2004, 39:55-60.
14. Brolund A., Wisell K.T., Edquist P.J., Elfstrom L., Walder M., Giske C.G. Development of a real-time SYBR Green PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae. J Microbiol Methods 2010, 82:229-233.
15. Bueno M.F., Francisco G.R., O'Hara J.A., de Oliveira Garcia D., Doi Y. Coproduction of 16S rRNA Methyltransferase RmtD or RmtG with KPC-2 and CTX-M Group Extended-Spectrum β-Lactamases in Klebsiella pneumoniae. Antimicrob Agents Chemother 2013, 57:2397-2400.
16. Burckhardt I., Zimmermann S. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J Clin Microbiol 2011, 49:3321-3324.
17. Bush K., Jacoby G.A. Updated functional classification of β-lactamases. Antimicrob Agents Chemother 2009, 54:969-976.
18. Bush K., Pannell M., Lock J.L., Queenan A.M., Jorgensen J.H., Lee R.M., et al. Detection systems for carbapenemase gene identification should include the SME serine carbapenemase. Int J Antimicrob Agents 2013, 41:1-4.
19. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622.
20. Cai J.C., Hu Y.Y., Zhang R., Zhou H.W., Chen G.X. Detection of OmpK36 porin loss in Klebsiella spp. by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2012, 50:2179-2182.
21. Camara J.E., Hays F.A. Discrimination between wild-type and ampicillin-resistant Escherichia coli by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Bioanal Chem 2007, 389:1633-1638.
22. Capone A., Giannella M., Fortini D., Giordano A., Meledandri M., Ballardini M., et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 2013, 19:E23-E30.
23. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007, 60:394-397.
24. KPC) variants. J Clin Microbiol 2011, 49:579-585.
25. Chen L., Chavda K.D., Mediavilla J.R., Zhao Y., Fraimow H.S., Jenkins S.G., et al. Multiplex real-time PCR for detection of an epidemic KPC-producing Klebsiella pneumoniae ST258 clone. Antimicrob Agents Chemother 2012, 56:3444-3447.
26. Cohen Stuart J., Dierikx C., Al Naiemi N., Karczmarek A., Van Hoek A.H., Vos P., et al. Rapid detection of TEM, SHV and CTX-M extended-spectrum β-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother 2010, 65:1377-1381.
27. Coque T.M., Baquero F., Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008, 13.
28. Cuzon G., Naas T., Bogaerts P., Glupczynski Y., Nordmann P. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother 2012, 67:1865-1869.
29. Dallenne C., Da Costa A., Decre D., Favier C., Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010, 65:490-495.
30. De Champs C., Chanal C., Sirot D., Baraduc R., Romaszko J.P., Bonnet R., et al. Frequency and diversity of Class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother 2004, 54:634-639.
31. Diaz M.A., Cooper R.K., Cloeckaert A., Siebeling R.J. Plasmid-mediated high-level gentamicin resistance among enteric bacteria isolated from pet turtles in Louisiana. Appl Environ Microbiol 2006, 72:306-312.
32. Doi Y., Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 2007, 45:88-94.
33. Doi Y., Paterson D.L. Detection of plasmid-mediated class C β-lactamases. Int J Infect Dis 2007, 11:191-197.
34. Donnenberg M. Enterobacteriaceae. Principles and practice of infectious diseases 2005, 2567-2586. Churchill Livingstone. Sixth Ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
35. Doumith M., Ellington M.J., Livermore D.M., Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009, 63:659-667.
36. Doyle D., Peirano G., Lascols C., Lloyd T., Church D.L., Pitout J.D. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol 2012, 50:3877-3880.
37. Drieux L., Brossier F., Sougakoff W., Jarlier V. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008, 14(Suppl 1):90-103.
38. Ecker J.A., Massire C., Hall T.A., Ranken R., Pennella T.T., Agasino Ivy C., et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol 2006, 44:2921-2932.
39. Ecker D.J., Sampath R., Massire C., Blyn L.B., Hall T.A., Eshoo M.W., et al. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 2008, 6:553-558.
40. Ellington M.J., Kistler J., Livermore D.M., Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J Antimicrob Chemother 2007, 59:321-322.
41. Emonet S., Shah H.N., Cherkaoui A., Schrenzel J. Application and use of various mass spectrometry methods in clinical microbiology. Clin Microbiol Infect 2010, 16:1604-1613.
42. Endimiani A., Paterson D.L. Optimizing therapy for infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases. Semin Respir Crit Care Med 2007, 28:646-655.
43. Endimiani A., Tamborini A., Luzzaro F., Lombardi G., Toniolo A. Epidemiology of bloodstream infections and time to detection of positive blood cultures: an evaluation of the automated BacT/Alert and BACTEC 9240 systems. New Microbiol 2002, 25:9-16.
44. Endimiani A., Luzzaro F., Perilli M., Lombardi G., Coli A., Tamborini A., et al. Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum β-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin. Clin Infect Dis 2004, 38:243-251.
45. Endimiani A., Luzzaro F., Brigante G., Perilli M., Lombardi G., Amicosante G., et al. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005, 49:2598-2605.
46. KPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009, 64:1102-1110.
47. Endimiani A., Hujer A.M., Hujer K.M., Gatta J.A., Schriver A.C., Jacobs M.R., et al. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type β-lactamase genes in Gram-negative isolates. J Clin Microbiol 2010, 48:2618-2622.
48. KPC-possessing Enterobacteriaceae by PCR/electrospray ionization-mass spectrometry. J Antimicrob Chemother 2010, 65:1833-1834.
49. Endimiani A., Hujer K.M., Hujer A.M., Kurz S., Jacobs M.R., Perlin D.S., et al. Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?. Clin Infect Dis 2011, 52(Suppl 4):S373-S383.
50. Endimiani A., Rossano A., Kunz D., Overesch G., Perreten V. First countrywide survey of third-generation cephalosporin-resistant Escherichia coli from broilers, swine, and cattle in Switzerland. Diagn Microbiol Infect Dis 2012, 73:31-38.
51. Erali M., Voelkerding K.V., Wittwer C.T. High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol 2008, 85:50-58.
52. Faria-Ramos I., Espinar M.J., Rocha R., Santos-Antunes J., Rodrigues A.G., Canton R., et al. A novel flow cytometric assay for rapid detection of extended-spectrum β-lactamases. Clin Microbiol Infect 2013, 19:E8-E15.
53. Fishbain J.T., Sinyavskiy O., Riederer K., Hujer A.M., Bonomo R.A. Detection of extended-spectrum β-lactamase and Klebsiella pneumoniae Carbapenemase genes directly from blood cultures by use of a nucleic acid microarray. J Clin Microbiol 2012, 50:2901-2904.
54. Fujita S., Yosizaki K., Ogushi T., Uechi K., Takemori Y., Senda Y. Rapid identification of gram-negative bacteria with and without CTX-M extended-spectrum β-lactamase from positive blood culture bottles by PCR followed by microchip gel electrophoresis. J Clin Microbiol 2011, 49:1483-1488.
55. Galimand M., Sabtcheva S., Courvalin P., Lambert T. Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob Agents Chemother 2005, 49:2949-2953.
56. Gaynes R., Edwards J.R. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005, 41:848-854.
57. Geyer C.N., Reisbig M.D., Hanson N.D. Development of a TaqMan multiplex PCR assay for detection of plasmid-mediated ampC β-lactamase genes. J Clin Microbiol 2012, 50:3722-3725.
58. Giamarellou H., Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options?. Drugs 2009, 69:1879-1901.
59. Girlich D., Poirel L., Szczepanowski R., Schluter A., Nordmann P. Carbapenem-hydrolyzing GES-5-encoding gene on different plasmid types recovered from a bacterial community in a sewage treatment plant. Appl Environ Microbiol 2012, 78:1292-1295.
60. Gniadkowski M. Evolution of extended-spectrum β-lactamases by mutation. Clin Microbiol Infect 2008, 14(Suppl 1):11-32.
61. Grayson, M, L., (2010) Cephalosporins and Related Drugs. In Kocers' the Use of Antibiotics. ASM Press (6th ed).
62. Grimm V., Ezaki S., Susa M., Knabbe C., Schmid R.D., Bachmann T.T. Use of DNA microarrays for rapid genotyping of TEM β-lactamases that confer resistance. J Clin Microbiol 2004, 42:3766-3774.
63. Guillard T., Duval V., Moret H., Brasme L., Vernet-Garnier V., de Champs C. Rapid detection of aac(6')-Ib-cr quinolone resistance gene by pyrosequencing. J Clin Microbiol 2010, 48:286-289.
64. Guillard T., Moret H., Brasme L., Carlier A., Vernet-Garnier V., Cambau E., et al. Rapid detection of qnr and qepA plasmid-mediated quinolone resistance genes using real-time PCR. Diagn Microbiol Infect Dis 2011, 70:253-259.
65. Guillard T., de Champs C., Moret H., Bertrand X., Scheftel J.M., Cambau E. High-resolution melting analysis for rapid characterization of qnr alleles in clinical isolates and detection of two novel alleles, qnrB25 and qnrB42. J Antimicrob Chemother 2012, 67:2635-2639.
66. Haanpera M., Forssten S.D., Huovinen P., Jalava J. Typing of SHV extended-spectrum β-lactamases by pyrosequencing in Klebsiella pneumoniae strains with chromosomal SHV β-lactamase. Antimicrob Agents Chemother 2008, 52:2632-2635.
67. Hammond D.S., Schooneveldt J.M., Nimmo G.R., Huygens F., Giffard P.M. bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates. Antimicrob Agents Chemother 2005, 49:256-263.
68. Hamprecht A., Poirel L., Gottig S., Seifert H., Kaase M., Nordmann P. Detection of the carbapenemase GIM-1 in Enterobacter cloacae in Germany. J Antimicrob Chemother 2013, 68:558-561.
69. Hansen L.H., Johannesen E., Burmolle M., Sorensen A.H., Sorensen S.J. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 2004, 48:3332-3337.
70. Hansen L.H., Jensen L.B., Sorensen H.I., Sorensen S.J. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J Antimicrob Chemother 2007, 60:145-147.
71. Harris P.N., Ferguson J.K. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?. Int J Antimicrob Agents 2012, 40:297-305.
72. Hawser S.P., Bouchillon S.K., Hoban D.J., Badal R.E., Canton R., Baquero F. Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum β-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2010, 54:3043-3046.
73. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res 1996, 6:986-994.
74. Hidalgo L., Hopkins K.L., Gutierrez B., Ovejero C.M., Shukla S., Douthwaite S., et al. Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK. J Antimicrob Chemother 2013.
75. Higuchi R., Dollinger G., Walsh P.S., Griffith R. Simultaneous amplification and detection of specific DNA sequences. Biotechnology (N Y) 1992, 10:413-417.
76. Higuchi R., Fockler C., Dollinger G., Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y) 1993, 11:1026-1030.
77. Hilty M., Sendi P., Seiffert S.N., Droz S., Perreten V., Hujer A.M., et al. Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?. Int J Antimicrob Agents 2013, 41:236-249.
78. KPC carbapenemase genes by real-time PCR. J Clin Microbiol 2008, 46:2879-2883.
79. KPC carbapenemase genes by internally controlled real-time PCR assay using bactec blood culture bottles. J Clin Microbiol 2011, 49:2480-2484.
80. Ho Y.P., Reddy P.M. Advances in mass spectrometry for the identification of pathogens. Mass Spectrom Rev 2011, 30:1203-1224.
81. Hong S.S., Kim K., Huh J.Y., Jung B., Kang M.S., Hong S.G. Multiplex PCR for rapid detection of genes encoding class A carbapenemases. Ann Lab Med 2012, 32:359-361.
82. Hooff G.P., van Kampen J.J., Meesters R.J., van Belkum A., Goessens W.H., Luider T.M. Characterization of β-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry. J Proteome Res 2012, 11:79-84.
83. Hooper D.C. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 2001, 32(Suppl 1):S9-S15.
84. Hopkins K.L., Arnold C., Threlfall E.J. Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology. J Microbiol Methods 2007, 68:163-171.
85. Hornsey M., Phee L., Wareham D.W. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother 2011, 55:5952-5954.
86. Hrabak J., Walkova R., Studentova V., Chudackova E., Bergerova T. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2011, 49:3222-3227.
87. Hrabak J., Studentova V., Walkova R., Zemlickova H., Jakubu V., Chudackova E., et al. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2012, 50:2441-2443.
88. Hrabak J., Chudackova E., Walkova R. Matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin Microbiol Rev 2013, 26:103-114.
89. Ikryannikova L.N., Shitikov E.A., Zhivankova D.G., Il'ina E.N., Edelstein M.V., Govorun V.M. A MALDI TOF MS-based minisequencing method for rapid detection of TEM-type extended-spectrum β-lactamases in clinical strains of Enterobacteriaceae. J Microbiol Methods 2008, 75:385-391.
90. Jacoby G.A. Mechanisms of resistance to quinolones. Clin Infect Dis 2005, 41(Suppl 2):S120-S126.
91. Jacoby G.A. AmpC β-lactamases. Clin Microbiol Rev 2009, 22:161-182.
92. TEM-155. Antimicrob Agents Chemother 2009, 53:977-986.
93. Jorgensen R.L., Nielsen J.B., Friis-Moller A., Fjeldsoe-Nielsen H., Schonning K. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. J Antimicrob Chemother 2010, 65:460-464.
94. Kaase M., Szabados F., Wassill L., Gatermann S.G. Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR. J Clin Microbiol 2012, 50:3115-3118.
95. Karah N., Poirel L., Bengtsson S., Sundqvist M., Kahlmeter G., Nordmann P., et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. Diagn Microbiol Infect Dis 2010, 66:425-431.
96. Kim H.B., Wang M., Park C.H., Kim E.C., Jacoby G.A., Hooper D.C. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother 2009, 53:3582-3584.
97. Kishii R., Takei M. Relationship between the expression of ompF and quinolone resistance in Escherichia coli. J Infect Chemother 2009, 15:361-366.
98. NDM-1). Med Microbiol Immunol 2011, 200:137-141.
99. CMY-2 genes in clinical isolates of Escherichia coli. J Antimicrob Chemother 2011, 66:1734-1738.
100. Landman D., Bratu S., Quale J. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 2009, 58:1303-1308.
101. Lascols C., Hackel M., Hujer A.M., Marshall S.H., Bouchillon S.K., Hoban D.J., et al. Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world. J Clin Microbiol 2012, 50:1632-1639.
102. Lascols C., Peirano G., Hackel M., Laupland K.B., Pitout J.D. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce Carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother 2013, 57:130-136.
103. Lavigne J.P., Espinal P., Dunyach-Remy C., Messad N., Pantel A., Sotto A. Mass spectrometry: a revolution in clinical microbiology?. Clin Chem Lab Med 2012, 1-14.
104. Lee S.Y., Kotapati S., Kuti J.L., Nightingale C.H., Nicolau D.P. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 2006, 27:1226-1232.
105. DHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β-lactamases. J Antimicrob Chemother 2007, 60:410-413.
106. Leinberger D.M., Grimm V., Rubtsova M., Weile J., Schroppel K., Wichelhaus T.A., et al. Integrated detection of extended-spectrum-β-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes. J Clin Microbiol 2010, 48:460-471.
107. Liu L., Li Y., Li S., Hu N., He Y., Pong R., et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol 2012, 2012:251364.
108. Liu W., Zou D., Li Y., Wang X., He X., Wei X., et al. Sensitive and rapid detection of the new Delhi metallo-β-lactamase gene by loop-mediated isothermal amplification. J Clin Microbiol 2012, 50:1580-1585.
109. Livermore D.M., Canton R., Gniadkowski M., Nordmann P., Rossolini G.M., Arlet G., et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007, 59:165-174.
110. Livermore D.M., Warner M., Mushtaq S., Doumith M., Zhang J., Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011, 37:415-419.
111. Livermore D.M., Andrews J.M., Hawkey P.M., Ho P.L., Keness Y., Doi Y., et al. Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?. J Antimicrob Chemother 2012, 67:1569-1577.
112. Lou H., Chen M., Black S.S., Bushell S.R., Ceccarelli M., Mach T., et al. Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant E. coli. PLoS One 2011, 6:e25825.
113. Luzzaro F., Gesu G., Endimiani A., Ortisi G., Malandrin S., Pagani L., et al. Performance in detection and reporting β-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories. Diagn Microbiol Infect Dis 2006, 55:311-318.
114. Magnet S., Blanchard J.S. Molecular insights into aminoglycoside action and resistance. Chem Rev 2005, 105:477-498.
115. Manchanda V., Rai S., Gupta S., Rautela R.S., Chopra R., Rawat D.S., et al. Development of TaqMan real-time polymerase chain reaction for the detection of the newly emerging form of carbapenem resistance gene in clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii. Indian J Med Microbiol 2011, 29:249-253.
116. Markoulatos P., Siafakas N., Moncany M. Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal 2002, 16:47-51.
117. Mathers A.J., Hazen K.C., Carroll J., Yeh A.J., Cox H.L., Bonomo R.A., et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol 2013, 51:680-683.
118. Maxam A.M., Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A 1977, 74:560-564.
119. McDonald L.C., Chen F.J., Lo H.J., Yin H.C., Lu P.L., Huang C.H., et al. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother 2001, 45:3084-3091.
120. Meyer E., Schwab F., Schroeren-Boersch B., Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 2010, 14:R113.
121. Michalopoulos A., Falagas M.E. Treatment of Acinetobacter infections. Expert Opin Pharmacother 2010, 11:779-788.
122. Miller M.B., Tang Y.W. Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev 2009, 22:611-633.
123. Miro E., Grunbaum F., Gomez L., Rivera A., Mirelis B., Coll P., et al. Characterization of aminoglycoside-modifying enzymes in Enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion. Microb Drug Resist 2012.
124. Monteiro J., Widen R.H., Pignatari A.C., Kubasek C., Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 2012, 67:906-909.
125. TEM evolution. Antimicrob Agents Chemother 2008, 52:2340-2345.
126. Mullis K.B., Faloona F.A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987, 155:335-350.
127. Murray K.K. DNA sequencing by mass spectrometry. J Mass Spectrom 1996, 31:1203-1215.
128. Naas T., Massuard S., Garnier F., Nordmann P. AmpD is required for regulation of expression of NmcA, a carbapenem-hydrolyzing β-lactamase of Enterobacter cloacae. Antimicrob Agents Chemother 2001, 45:2908-2915.
129. Naas T., Oxacelay C., Nordmann P. Identification of CTX-M-type extended-spectrum-β-lactamase genes using real-time PCR and pyrosequencing. Antimicrob Agents Chemother 2007, 51:223-230.
130. Naas T., Cuzon G., Truong H., Bernabeu S., Nordmann P. Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and KPC carbapenemases. Antimicrob Agents Chemother 2010, 54:3086-3092.
131. Naas T., Cuzon G., Bogaerts P., Glupczynski Y., Nordmann P. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol 2011, 49:1608-1613.
132. Naas T., Ergani A., Carrer A., Nordmann P. Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother 2011, 55:4038-4043.
133. OXA-48 genes from stools. J Antimicrob Chemother 2013, 68:101-104.
134. Nijhuis R., van Zwet A., Stuart J.C., Weijers T., Savelkoul P. Rapid molecular detection of extended-spectrum β-lactamase gene variants with a novel ligation-mediated real-time PCR. J Med Microbiol 2012, 61:1563-1567.
135. Nordmann P., Naas T., Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011, 17:1791-1798.
136. Nordmann P., Poirel L., Carrer A., Toleman M.A., Walsh T.R. How to detect NDM-1 producers. J Clin Microbiol 2011, 49:718-721.
137. Nordmann P., Poirel L., Walsh T.R., Livermore D.M. The emerging NDM carbapenemases. Trends Microbiol 2011, 19:588-595.
138. Nordmann P., Dortet L., Poirel L. Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae. J Clin Microbiol 2012, 50:3016-3022.
139. Nordmann P., Gniadkowski M., Giske C.G., Poirel L., Woodford N., Miriagou V. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012, 18:432-438.
140. Nordmann P., Poirel L., Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2012, 18:1503-1507.
141. Notomi T., Okayama H., Masubuchi H., Yonekawa T., Watanabe K., Amino N., et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000, 28:E63.
142. Oteo J., Delgado-Iribarren A., Vega D., Bautista V., Rodriguez M.C., Velasco M., et al. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int J Antimicrob Agents 2008, 32:534-537.
143. Oxacelay C., Ergani A., Naas T., Nordmann P. Rapid detection of CTX-M-producing Enterobacteriaceae in urine samples. J Antimicrob Chemother 2009, 64:986-989.
144. Papp-Wallace K.M., Endimiani A., Taracila M.A., Bonomo R.A. Carbapenems: past, present, and future. Antimicrob Agents Chemother 2011, 55:4943-4960.
145. Park C.H., Robicsek A., Jacoby G.A., Sahm D., Hooper D.C. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006, 50:3953-3955.
146. Park K.S., Kim M.H., Park T.S., Nam Y.S., Lee H.J., Suh J.T. Prevalence of the plasmid-mediated quinolone resistance genes, aac(6')-Ib-cr, qepA, and oqxAB in clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Korea. Ann Clin Lab Sci 2012, 42:191-197.
147. Paterson D.L., Bonomo R.A. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
148. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
149. Perichon B., Courvalin P., Galimand M. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother 2007, 51:2464-2469.
150. Perilli M., Celenza G., De Santis F., Pellegrini C., Forcella C., Rossolini G.M., et al. E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum β-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates. Antimicrob Agents Chemother 2008, 52:915-919.
151. Peter H., Berggrav K., Thomas P., Pfeifer Y., Witte W., Templeton K., et al. Direct detection and genotyping of Klebsiella pneumoniae carbapenemases from urine by use of a new DNA microarray test. J Clin Microbiol 2012, 50:3990-3998.
152. Pitout J.D., Hossain A., Hanson N.D. Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004, 42:5715-5721.
153. Pitout J.D., Gregson D.B., Poirel L., McClure J.A., Le P., Church D.L. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J Clin Microbiol 2005, 43:3129-3135.
154. Pitout J.D., Wei Y., Church D.L., Gregson D.B. Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6')-Ib-cr. J Antimicrob Chemother 2008, 61:999-1002.
155. Platteel T.N., Stuart J.W., Voets G.M., Scharringa J., van de Sande N., Fluit A.C., et al. Evaluation of a commercial microarray as a confirmation test for the presence of extended-spectrum β-lactamases in isolates from the routine clinical setting. Clin Microbiol Infect 2011, 17:1435-1438.
156. Poirel L., Le Thomas I., Naas T., Karim A., Nordmann P. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 2000, 44:622-632.
157. Poirel L., Naas T., Nordmann P. Pyrosequencing as a rapid tool for identification of GES-type extended-spectrum β-lactamases. J Clin Microbiol 2006, 44:3008-3011.
158. Poirel L., Walsh T.R., Cuvillier V., Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011, 70:119-123.
159. Poirel L., Potron A., Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012, 67:1597-1606.
160. Poritz M.A., Blaschke A.J., Byington C.L., Meyers L., Nilsson K., Jones D.E., et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One 2011, 6:e26047.
161. Pournaras S., Poulou A., Tsakris A. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother 2010, 65:1319-1321.
162. Predari S.C., Ligozzi M., Fontana R. Genotypic identification of methicillin-resistant coagulase-negative staphylococci by polymerase chain reaction. Antimicrob Agents Chemother 1991, 35:2568-2573.
163. Qiang Y.Z., Qin T., Fu W., Cheng W.P., Li Y.S., Yi G. Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother 2002, 49:549-552.
164. Raghunathan A., Samuel L., Tibbetts R.J. Evaluation of a real-time PCR assay for the detection of the Klebsiella pneumoniae carbapenemase genes in microbiological samples in comparison with the modified Hodge test. Am J Clin Pathol 2011, 135:566-571.
165. Randegger C.C., Keller A., Irla M., Wada A., Hachler H. Contribution of natural amino acid substitutions in SHV extended-spectrum β-lactamases to resistance against various β-lactams. Antimicrob Agents Chemother 2000, 44:2759-2763.
166. Rapp R.P., Urban C. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy 2012, 32:399-407.
167. Riedel S., Carroll K.C. Blood cultures: key elements for best practices and future directions. J Infect Chemother 2010, 16:301-316.
168. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006, 50:2872-2874.
169. IMI-2 gene in a clinical Escherichia coli strain. Antimicrob Agents Chemother 2012, 56:1146-1147.
170. Ronaghi M., Karamohamed S., Pettersson B., Uhlen M., Nyren P. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 1996, 242:84-89.
171. Rossolini G.M., D'Andrea M.M., Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect 2008, 14(Suppl 1):33-41.
172. Rubtsova M.Y., Ulyashova M.M., Edelstein M.V., Egorov A.M. Oligonucleotide microarrays with horseradish peroxidase-based detection for the identification of extended-spectrum β-lactamases. Biosens Bioelectron 2010, 26:1252-1260.
173. CTX-M-15, qnrS1 and aac(6')-Ib-cr genes. J Med Microbiol 2012, 61:672-677.
174. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977, 74:5463-5467.
175. Schaumann R., Knoop N., Genzel G.H., Losensky K., Rosenkranz C., Stingu C.S., et al. A step towards the discrimination of β-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med Sci Monit 2012, 18:MT71-MT77.
176. Schrader C., Schielke A., Ellerbroek L., Johne R. PCR inhibitors - occurrence, properties and removal. J Appl Microbiol 2012, 113:1014-1026.
177. Schwaber M.J., Navon-Venezia S., Kaye K.S., Ben-Ami R., Schwartz D., Carmeli Y. Clinical and economic impact of bacteremia with extended- spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006, 50:1257-1262.
178. Seiffert S.N., Hilty M., Perreten V., Endimiani A. Extended-spectrum cephalosporin-resistant gram-negative organisms in livestock: An emerging problem for human health?. Drug Resist Updat 2013.
179. Sherry N.L., Porter J.L., Seemann T., Watkins A., Stinear T.P., Howden B.P. Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory. J Clin Microbiol 2013.
180. Sibley C.D., Peirano G., Church D.L. Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology. Infect Genet Evol 2012, 12:505-521.
181. Singh K., Mangold K.A., Wyant K., Schora D.M., Voss B., Kaul K.L., et al. Rectal screening for Klebsiella pneumoniae carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates. J Clin Microbiol 2012, 50:2596-2600.
182. KPC). J Clin Microbiol 2012, 50:2783-2785.
183. Sparbier K., Schubert S., Weller U., Boogen C., Kostrzewa M. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. J Clin Microbiol 2012, 50:927-937.
184. Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009, 22:664-689.
185. Sturenburg E., Storm N., Sobottka I., Horstkotte M.A., Scherpe S., Aepfelbacher M., et al. Detection and genotyping of SHV β-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts. J Clin Microbiol 2006, 44:909-915.
186. Swayne R.L., Ludlam H.A., Shet V.G., Woodford N., Curran M.D. Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2011, 38:35-38.
187. Tangden T., Adler M., Cars O., Sandegren L., Lowdin E. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. J Antimicrob Chemother 2013.
188. Tong S.Y., Giffard P.M. Microbiological applications of high-resolution melting analysis. J Clin Microbiol 2012, 50:3418-3421.
189. Tsai Y.K., Fung C.P., Lin J.C., Chen J.H., Chang F.Y., Chen T.L., et al. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 2011, 55:1485-1493.
190. Tumbarello M., Sanguinetti M., Montuori E., Trecarichi E.M., Posteraro B., Fiori B., et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007, 51:1987-1994.
191. Tumbarello M., Spanu T., Di Bidino R., Marchetti M., Ruggeri M., Trecarichi E.M., et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-β-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 2010, 54:4085-4091.
192. Voets G.M., Fluit A.C., Scharringa J., Cohen Stuart J., Leverstein-van Hall M.A. A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Int J Antimicrob Agents 2011, 37:356-359.
193. Walsh T.R. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010, 36(Suppl 3):S8-S14.
194. Walther-Rasmussen J., Hoiby N. Class A carbapenemases. J Antimicrob Chemother 2007, 60:470-482.
195. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003, 47:2242-2248.
196. Weigel L.M., Steward C.D., Tenover F.C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob Agents Chemother 1998, 42:2661-2667.
197. Wieser A., Schneider L., Jung J., Schubert S. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review). Appl Microbiol Biotechnol 2012, 93:965-974.
198. Williamson D.A., Sidjabat H.E., Freeman J.T., Roberts S.A., Silvey A., Woodhouse R., et al. Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. Int J Antimicrob Agents 2012, 39:529-533.
199. Wintermans B.B., Reuland E.A., Wintermans R.G., Bergmans A.M., Kluytmans J.A. The cost-effectiveness of ESBL detection: towards molecular detection methods?. Clin Microbiol Infect 2012.
200. Wolk D.M., Kaleta E.J., Wysocki V.H. PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn 2012, 14:295-304.
201. Xiao W., Oefner P.J. Denaturing high-performance liquid chromatography: A review. Hum Mutat 2001, 17:439-474.
202. Xu L., Evans J., Ling T., Nye K., Hawkey P. Rapid genotyping of CTX-M extended-spectrum β-lactamases by denaturing high-performance liquid chromatography. Antimicrob Agents Chemother 2007, 51:1446-1454.
203. Yamane K., Wachino J., Suzuki S., Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 2008, 52:1564-1566.
204. Yan J.J., Wu J.J., Ko W.C., Tsai S.H., Chuang C.L., Wu H.M., et al. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J Antimicrob Chemother 2004, 54:1007-1012.
205. Yue L., Jiang H.X., Liao X.P., Liu J.H., Li S.J., Chen X.Y., et al. Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli. Vet Microbiol 2008, 132:414-420.
206. Zhou X.Y., Bordon F., Sirot D., Kitzis M.D., Gutmann L. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob Agents Chemother 1994, 38:1085-1089.